Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-002614-36Phase 3Terminated
Phase 3, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by IBSA Group. Primary endpoint: Change in serum free T4. Started Jan 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-002614-36.